News | July 12, 2025
Evonik opens new medical device center in Shanghai
The company’s largest center for medical device applications, serving the entire Asian market
The company’s largest center for medical device applications, serving the entire Asian market
Increases speed to market for drug developers working on nucleic acid therapeutics
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
One thousand times more soluble than L-cystine at neutral pH
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Subscribe To Our Newsletter & Stay Updated
